Meta Pixel

News and Announcements

Endeavour Drinks Group (Operated by Woolworths Ltd) Signs Deal with OpenDNA (ASX:OPN) to Use AI Technology to Improve Customer Experience

  • Published July 17, 2017 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

OpenDNA Limited (ASX: OPN) has recently announced the a signed customer agreement with Endeavour Drinks Group, a business element operated by Woolworths Limited.

KEY TAKEAWAYS: 

  • Agreement signed with Endeavour Drinks Group, a business which is operated by Woolworths Limited and which also is the owner of Dan Murphy’s, BWS and CellarMasters brands amongst others.
  • OpenDNA and Endeavour have spoken to create and launch an app, which will provide users with the ability to choose “off the shelf” the best alcoholic beverage selection for their instantaneous needs.
  • Through the app, consumers will be able to create a library of potential products tailored to their specific interests with also reflecting their preferences across a range of situations, moods and events.
  • OpenDNA will create and power the app, generating revenue in the form of both app development and ongoing usage fee.

Speaking today in relation to the signing of the Agreement, OpenDNA CEO and MD Jay Shah said: “We are delighted to partner with a household name and trusted brand in the form of Endeavour Drinks Group to deliver to consumers an innovative and personalized app, which enables them to select the perfect accompaniment to any occasion. Through use of OpenDNA technology, not only will the app allow individual users to capture and catalogue their preferences for future reference, it will also enable them to access Endeavour’s extensive associated knowledge base to ensure that they receive the best and most personalised experience”.

Request Information

Capital Insights
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula

Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.

Join over 45,000+ sophisticated investors

Join Now